274 related articles for article (PubMed ID: 30178230)
1. Variable spectrum of disease and risk factors of peripartum Clostridium difficile infection: report of 14 cases from French hospitals and literature review.
de Curraize C; Rousseau C; Corvec S; El-Helali N; Fihman V; Barbut F; Collignon A; Le Monnier A
Eur J Clin Microbiol Infect Dis; 2018 Dec; 37(12):2293-2299. PubMed ID: 30178230
[TBL] [Abstract][Full Text] [Related]
2. Peripartum Clostridium difficile infection: case series and review of the literature.
Garey KW; Jiang ZD; Yadav Y; Mullins B; Wong K; Dupont HL
Am J Obstet Gynecol; 2008 Oct; 199(4):332-7. PubMed ID: 18639213
[TBL] [Abstract][Full Text] [Related]
3. The evaluation of Clostridium difficile infection (CDI) in a community hospital.
Daniel A; Rapose A
J Infect Public Health; 2015; 8(2):155-60. PubMed ID: 25301221
[TBL] [Abstract][Full Text] [Related]
4. [Clostridium difficile infection: epidemiology, risk factors, pathogenesis, clinical features, diagnosis and therapy].
Kılıç A
Mikrobiyol Bul; 2013 Jul; 47(3):556-66. PubMed ID: 23971935
[TBL] [Abstract][Full Text] [Related]
5. Clostridium difficile infection (CDI) severity and outcome among patients infected with the NAP1/BI/027 strain in a non-epidemic setting.
Scardina T; Labuszewski L; Pacheco SM; Adams W; Schreckenberger P; Johnson S
Infect Control Hosp Epidemiol; 2015 Mar; 36(3):280-6. PubMed ID: 25695169
[TBL] [Abstract][Full Text] [Related]
6. Clostridium difficile infection in older adults: a review and update on its management.
Kee VR
Am J Geriatr Pharmacother; 2012 Feb; 10(1):14-24. PubMed ID: 22260856
[TBL] [Abstract][Full Text] [Related]
7. Changing epidemiology of Clostridium difficile infection following the introduction of a national ribotyping-based surveillance scheme in England.
Wilcox MH; Shetty N; Fawley WN; Shemko M; Coen P; Birtles A; Cairns M; Curran MD; Dodgson KJ; Green SM; Hardy KJ; Hawkey PM; Magee JG; Sails AD; Wren MW
Clin Infect Dis; 2012 Oct; 55(8):1056-63. PubMed ID: 22784871
[TBL] [Abstract][Full Text] [Related]
8. Clinical features and characteristics of Clostridium difficile PCR-ribotype 176 infection: results from a 1-year university hospital internal ward study.
Drabek J; Nyc O; Krutova M; Stovicek J; Matejkova J; Keil R
Ann Clin Microbiol Antimicrob; 2015 Dec; 14():55. PubMed ID: 26698842
[TBL] [Abstract][Full Text] [Related]
9. Clostridium difficile infection among immunocompromised patients in Rio de Janeiro, Brazil and detection of moxifloxacin resistance in a ribotype 014 strain.
Secco DA; Balassiano IT; Boente RF; Miranda KR; Brazier J; Hall V; dos Santos-Filho J; Lobo LA; Nouér SA; Domingues RM
Anaerobe; 2014 Aug; 28():85-9. PubMed ID: 24907488
[TBL] [Abstract][Full Text] [Related]
10. Clostridium difficile ribotype 027: relationship to age, detectability of toxins A or B in stool with rapid testing, severe infection, and mortality.
Rao K; Micic D; Natarajan M; Winters S; Kiel MJ; Walk ST; Santhosh K; Mogle JA; Galecki AT; LeBar W; Higgins PD; Young VB; Aronoff DM
Clin Infect Dis; 2015 Jul; 61(2):233-41. PubMed ID: 25828993
[TBL] [Abstract][Full Text] [Related]
11. Factors associated with Clostridium difficile infection: A nested case-control study in a three year prospective cohort.
Khanafer N; Vanhems P; Barbut F; Luxemburger C; ; Demont C; Hulin M; Dauwalder O; Vandenesch F; ; Argaud L; Badet L; Barth X; Bertrand M; Burillon C; Chapurlat R; Chuzeville M; Comte B; Disant F; Fessy MH; Gouillat C; Juillard L; Lermusiaux P; Monneuse O; Morelon E; Ninet J; Ponchon T; Poulet E; Rimmele T; Tazarourte K
Anaerobe; 2017 Apr; 44():117-123. PubMed ID: 28279859
[TBL] [Abstract][Full Text] [Related]
12. Increasing incidence of Clostridium difficile ribotype 001 associated with severe course of the infection and previous fluoroquinolone use in the Czech Republic, 2015.
Krutova M; Matejkova J; Drevinek P; Kuijper EJ; Nyc O;
Eur J Clin Microbiol Infect Dis; 2017 Nov; 36(11):2251-2258. PubMed ID: 28681203
[TBL] [Abstract][Full Text] [Related]
13. Clostridium difficile infection rates and spectrum of disease among peripartum women at one hospital from 2003 to 2007 with molecular typing analysis of recovered Clostridium difficile isolates.
Venugopal AA; Gerding DN; Johnson S
Am J Infect Control; 2011 Apr; 39(3):206-11. PubMed ID: 21126802
[TBL] [Abstract][Full Text] [Related]
14. High morbidity and mortality of Clostridium difficile infection and its associations with ribotype 002 in Hong Kong.
Wong SH; Ip M; Hawkey PM; Lo N; Hardy K; Manzoor S; Hui WW; Choi KW; Wong RY; Yung IM; Cheung CS; Lam KL; Kwong T; Wu WK; Ng SC; Wu JC; Sung JJ; Lee N
J Infect; 2016 Aug; 73(2):115-22. PubMed ID: 27246801
[TBL] [Abstract][Full Text] [Related]
15. Emergence of Clostridium difficile tcdC variant 078 in Marseille, France.
Cassir N; Fahsi N; Durand G; Lagier JC; Raoult D; Fournier PE
Eur J Clin Microbiol Infect Dis; 2017 Oct; 36(10):1971-1974. PubMed ID: 28573471
[TBL] [Abstract][Full Text] [Related]
16. The epidemiology of Clostridioides difficile infection in Brazil: A systematic review covering thirty years.
Trindade CNR; Domingues RMCP; Ferreira EO
Anaerobe; 2019 Aug; 58():13-21. PubMed ID: 30851427
[TBL] [Abstract][Full Text] [Related]
17. Diversity of Clostridium difficile PCR ribotypes in Europe: results from the European, multicentre, prospective, biannual, point-prevalence study of Clostridium difficile infection in hospitalised patients with diarrhoea (EUCLID), 2012 and 2013.
Davies KA; Ashwin H; Longshaw CM; Burns DA; Davis GL; Wilcox MH;
Euro Surveill; 2016 Jul; 21(29):. PubMed ID: 27470194
[TBL] [Abstract][Full Text] [Related]
18. Risk of Clostridium difficile infection in hospitalized patients receiving metronidazole for a non-C difficile infection.
Rodriguez S; Hernandez MB; Tarchini G; Zaleski M; Vatanchi M; Cardona L; Castro-Pavia F; Schneider A
Clin Gastroenterol Hepatol; 2014 Nov; 12(11):1856-61. PubMed ID: 24681079
[TBL] [Abstract][Full Text] [Related]
19. [Clostridium-difficile-associated infections].
Eckert C; Barbut F
Med Sci (Paris); 2010 Feb; 26(2):153-8. PubMed ID: 20188046
[TBL] [Abstract][Full Text] [Related]
20. A case-control study of community-associated Clostridium difficile infection.
Wilcox MH; Mooney L; Bendall R; Settle CD; Fawley WN
J Antimicrob Chemother; 2008 Aug; 62(2):388-96. PubMed ID: 18434341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
